Osteoarthritis Market to See Rapid Growth, States Black Swan Analysis in Its In-demand Research Report Published at MarketPublishers.com
02 Nov 2016 • by Natalie Aster
LONDON – Osteoarthritis (OA), otherwise termed as degenerative joint disease (DJD), refers to an inflammation of the subchondral bone and arthrodial cartilage. It is the most typical kind of joint disorders, which is the main cause of pain and walking disability in the ageing population. Primary osteoarthritis and secondary osteoarthritis are the two most common forms of OA.
An increase in incidence rates of surgeries, various technology related advances, growing number of pipeline drugs, and increasing awareness about healthcare are amid the key factors boosting the world osteoarthritis market. Rising disposable personal income in developing nations is also among the main market drivers.
North America is currently the leading osteoarthritis market globally, with Europe following in tracks. This is owing to the growing prevalence of OA diseases and expanding geriatric population in the regions. Moreover, improved access to healthcare coverage, particularly in the USA, is also having a bearing on the growth of the OA market. Asia will likely record the fastest growth in the near term, owing to the growing healthcare infrastructure and various government incentives aimed at improving healthcare facilities, alongside a huge patient population base in the region.
Comprehensive report “Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026” elaborated by Black Swan Analysis examines the global OA marketplace, providing information on the current prevalent population for the disease in 9 major markets – the USA, Germany, France, Spain, Italy, the UK, Brazil, India and Japan. The data is broken down by gender and 5-year age cohort. The research study also contains an insightful overview of the risk factors associated with the disease, OA diagnosis and prognosis in tandem with distinct variations by geographical region and ethnicity. Alongside the overall prevalence figures, the report identifies several of the key symptoms and co-morbidities of OA. The study provides an analysis and forecast of the sub-populations within the major disease on a country scale.
More studies by the publisher can be found at Black Swan Analysis page.